ERBB2 and breast carcinoma: The presence or absence of these receptors defines the four distinct molecular subtypes of breast cancer- luminal A (ER/PR positive, HER2 negative), luminal B (ER and/or PR positive, HER2 positive), HER2 over-expressing (HER2 positive alone) and triple negative (negative for all 3 receptors) [3].